Cumulatively, data showed the shot to be 63% effective across the three-year period. However, efficacy appeared to wane and ...

While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

The RSV vaccine is unequivocally recommended for adults who are residents in skilled nursing and assisted living facilities.

Yes, the Centers for Disease Control and Prevention (CDC) does indeed recommend the pneumococcal vaccines for pneumonia for ...

GSK plc (GSK, GSK.L) announced Tuesday new data from the AReSVi-006 (Adult Respiratory Syncytial Virus) phase III trial evaluating ...

Launched in 2003 as part of CDC’s strategy for addressing the worldwide threat ... including playing a pivotal role in ...

Hospitalization Surveillance Network (RSV-NET) collects data to convey the trends in virus circulation and the high risk of infection among young children ...

Particularly if you tend not to have vaccine side effects, getting routine shots in one go may be a convenient option.

Officials are encouraging Connecticut residents to get their updated shots before the holiday season begins. Unlike COVID-19 ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

Although not all bats carry rabies, the city's health department wants people to seek post-exposure prophylaxis if they were bitten, scratched, or had contact with a bat. Meanwhile, travelers from ...

Over the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the multifactorial barriers including ...